Literature DB >> 11995772

Non-steroidal anti-inflammatory drugs and perforated diverticular disease: a case-control study.

H Goh1, R Bourne.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) have a wide range of side-effects in the gastrointestinal tract and the large intestine. This study examines the hypothesis that the use of NSAIDs is associated with colonic perforation in diverticular disease. Histological evidence was used to confirm perforation. A retrospective review of case records and pathology reports identified 20 patients admitted over 3 consecutive years. A total of 125 age- and sex-matched patients diagnosed with diverticular disease not complicated by perforation formed the control group. The incidences of NSAID use in the two groups were compared. A second control group consisted of 600 age- and sex-matched randomly selected patients with no known diverticular disease admitted as emergencies in the same period. Of the 20 patients with perforation, 9 were taking NSAIDs for 4 weeks or longer, compared with 19 (15%) of the 125 patients who did not have perforation (relative risk 2.961, 95% confidence interval 1.507-5.348, P < 0.01). 19% of all patients with diverticular disease were taking NSAIDs compared with 10% of the second control group (relative risk 1.869, 95% confidence interval 1.237-2.781, P < 0.01). The findings indicate a strong association between the use of NSAIDs and the perforation of colonic diverticula. The majority of the indications for the use of NSAIDs were cardiovascular and musculoskeletal conditions. Prescribing NSAIDs to patients with diverticular disease carries an increased risk of colonic perforation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11995772      PMCID: PMC2503782     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  21 in total

1.  Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study.

Authors:  K Campbell; R J Steele
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

Review 2.  Diverticulitis of the colon: evolution in concept and therapy.

Authors:  G V Rodkey; C E Welch
Journal:  Surg Clin North Am       Date:  1965-10       Impact factor: 2.741

3.  Steroids, non-steroidal anti-inflammatory drugs, and serious septic complications of diverticular disease.

Authors:  A Corder
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

4.  Intestinal perforation associated with osmotic slow release indomethacin capsules.

Authors:  T K Day
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

5.  Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study.

Authors:  R G Wilson; A N Smith; I M Macintyre
Journal:  Br J Surg       Date:  1990-10       Impact factor: 6.939

6.  Treatment of perforated diverticular disease of the colon.

Authors:  E J Hinchey; P G Schaal; G K Richards
Journal:  Adv Surg       Date:  1978

7.  Acute diverticulitis. A complicated problem in the immunocompromised patient.

Authors:  E S Tyau; J B Prystowsky; R J Joehl; D L Nahrwold
Journal:  Arch Surg       Date:  1991-07

8.  Inhibition of prostaglandin synthetase in human rectal mucosa.

Authors:  C J Hawkey; M Lo Casto
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

9.  Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

Authors:  M J Langman; L Morgan; A Worrall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02

Review 10.  Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

Authors:  I Bjarnason; J Hayllar; A J MacPherson; A S Russell
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  23 in total

Review 1.  Pathology of drug-associated gastrointestinal disease.

Authors:  Ashley B Price
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 2.  Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review.

Authors:  Taras Gout; Andrew J K Ostör; Muhammad K Nisar
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

Review 3.  Ageing and the gut.

Authors:  A L D'Souza
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

4.  [Modern therapy of diverticular disease].

Authors:  L Leifeld; W Kruis
Journal:  Internist (Berl)       Date:  2008-12       Impact factor: 0.743

Review 5.  Adverse effects of nonsteroidal anti-inflammatory drugs on the colon.

Authors:  Anne Ballinger
Journal:  Curr Gastroenterol Rep       Date:  2008-10

6.  Selective non-antibiotic treatment in sigmoid diverticulitis: is it time to change the traditional approach?

Authors:  O Estrada Ferrer; N Ruiz Edo; L-A Hidalgo Grau; M Abadal Prades; M Del Bas Rubia; E M Garcia Torralbo; A Heredia Budo; X Suñol Sala
Journal:  Tech Coloproctol       Date:  2016-04-06       Impact factor: 3.781

Review 7.  Management of diverticular disease.

Authors:  Roland H Pfützer; Wolfgang Kruis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-07-14       Impact factor: 46.802

8.  Italian consensus conference for colonic diverticulosis and diverticular disease.

Authors:  Rosario Cuomo; Giovanni Barbara; Fabio Pace; Vito Annese; Gabrio Bassotti; Gian Andrea Binda; Tino Casetti; Antonio Colecchia; Davide Festi; Roberto Fiocca; Andrea Laghi; Giovanni Maconi; Riccardo Nascimbeni; Carmelo Scarpignato; Vincenzo Villanacci; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

9.  Etiology and pathophysiology of diverticular disease.

Authors:  Kristina G Hobson; Patricia L Roberts
Journal:  Clin Colon Rectal Surg       Date:  2004-08

10.  Perforated colonic diverticular disease: the importance of NSAIDs, opioids, corticosteroids, and calcium channel blockers.

Authors:  Kristoffer Piekarek; Leif A Israelsson
Journal:  Int J Colorectal Dis       Date:  2008-08-05       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.